Citius Pharmaceuticals Inc. (CTXR)
Citius Oncology - Citius Oncology Announces U.S. Commercial Launch ofLYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
Citius Oncology - Citius Oncology Announces U.S. Commercial Launch ofLYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical